SCHEMBL20008404

SCHEMBL20008404

NS(=O)(=O)OC[C@@H]1CC[C@H](n2cnc3c(CNC(=O)c4cccnc4)ncnc32)O1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NAE1 Q13564 2/20 0.42
▸ UBA3 Q8TBC4 2/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ BCHE P06276 1/20 0.38
▸ ATG7 O95352 2/20 0.37
▸ UBA6 A0AVT1 1/20 0.37
▸ UBA7 P41226 1/20 0.37
▸ SAE1 Q9UBE0 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ CHKA P35790 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ALB P02768 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12567156 0.91 CYP1A2 (0.45) NAE1UBA3CYP1A2BCHEATG7
SCHEMBL18630487 0.86 NAE1 (0.46) NAE1UBA3ATG7
SCHEMBL23080227 0.85 BCHE (0.36) NAE1UBA3CYP1A2BCHEATG7
SCHEMBL1796003 0.83 TRPM2 (0.53) NAE1UBA3ATG7UBA6UBA7
SCHEMBL23080285 0.83 TRPM2 (0.53) NAE1UBA3ATG7UBA6UBA7
SCHEMBL12652414 0.78 UBA6 (0.47) NAE1UBA3CYP1A2BCHEATG7
SCHEMBL12567198 0.76 ATG7 (0.46) NAE1UBA3CYP1A2BCHEATG7
SCHEMBL17889829 0.75 BCHE (0.45) NAE1UBA3CYP1A2BCHEATG7
SCHEMBL12652415 0.75 BCHE (0.45) NAE1UBA3CYP1A2BCHEATG7
SCHEMBL13773372 0.74 BCHE (0.54) CYP1A2BCHEALDH1A1LMNAALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180086785-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES MILLENNIUM PHARMACEUTICALS, INC. 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086785-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES TYMP, TYMS, PPA1 NAE1 257/4885UBA3 235/4885CYP1A2 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback